UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Preliminary results of a randomised BNLI trial of chop vs CIOP (Idarubicin 10 mg/g(2) replacing hydroxydaunorubicin 50 mg/m(2)) in good prognosis younger patients with histologically aggressive non-Hodgkin's lymphoma (NHL).

Linch, DC; Smith, P; Gregory, WM; Hoskin, P; Cunningham, D; Hancock, BW; Rhodes, E; (1998) Preliminary results of a randomised BNLI trial of chop vs CIOP (Idarubicin 10 mg/g(2) replacing hydroxydaunorubicin 50 mg/m(2)) in good prognosis younger patients with histologically aggressive non-Hodgkin's lymphoma (NHL). BLOOD , 92 (10) 620A - 620A.

Full text not available from this repository.
Type: Article
Title: Preliminary results of a randomised BNLI trial of chop vs CIOP (Idarubicin 10 mg/g(2) replacing hydroxydaunorubicin 50 mg/m(2)) in good prognosis younger patients with histologically aggressive non-Hodgkin's lymphoma (NHL).
UCL classification: UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Haematology
URI: http://discovery.ucl.ac.uk/id/eprint/1308304
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item